Clinical Trial Update: ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing ATI-450 plus methotrexate to placebo plus methotrexate in adults with moderate-to-severe rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ATI-450
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED